Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 2
2006 1
2010 2
2011 1
2012 1
2013 1
2014 2
2015 1
2016 2
2017 3
2018 3
2020 1
2021 8
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models.
Panebianco C, Villani A, Pisati F, Orsenigo F, Ulaszewska M, Latiano TP, Potenza A, Andolfo A, Terracciano F, Tripodo C, Perri F, Pazienza V. Panebianco C, et al. Among authors: terracciano f. Biomed Pharmacother. 2022 Jul;151:113163. doi: 10.1016/j.biopha.2022.113163. Epub 2022 May 24. Biomed Pharmacother. 2022. PMID: 35617803 Free article.
Interobserver agreement of the Paris and simplified classifications of superficial colonic lesions: a Western study.
Cocomazzi F, Gentile M, Perri F, Merla A, Bossa F, Piazzolla M, Ippolito A, Terracciano F, Giuliani AP, Cubisino R, Marra A, Carparelli S, Mileti A, Paolillo R, Fontana A, Copetti M, Di Leo A, Andriulli A. Cocomazzi F, et al. Among authors: terracciano f. Endosc Int Open. 2021 Mar;9(3):E388-E394. doi: 10.1055/a-1352-3437. Epub 2021 Feb 19. Endosc Int Open. 2021. PMID: 33655038 Free PMC article.
Safety and efficacy of switching from infliximab biosimilar CT-P13 to infliximab biosimilar SB2 in patients with inflammatory bowel disease.
Lovero R, Losurdo G, La Fortezza RF, Terracciano F, Biscaglia G, Martino G, Nardella M, Di Leo A, Principi M, Andriulli A, Bossa F. Lovero R, et al. Among authors: terracciano f. Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):201-207. doi: 10.1097/MEG.0000000000001988. Eur J Gastroenterol Hepatol. 2021. PMID: 33369956
25 results